Ausgabe Sonderheft 1/2005
VI Madrid Breast Cancer Conference: Changes in the treatment of breast cancer
Inhalt (43 Artikel)
The role of gene expression profiling by microarray analysis for prognostic classification of breast cancer
MJ van de Vijver
Gene expression profiles and molecular classification to predict distant metastasis and tamoxifen-resistant breast cancer
JGM Klijn, EMJJ Berns, J Martens, MPHM Jansen, D Atkins, JA Foekens, Y Wang
Present situation and future of genetic profiling for prognosis and treatment
GN Hortobagyi
The roles of PET and CT/PET as preoperative studies
RC Delgado-Bolton, JL Carreras Delgado
Minimal residual disease (MRD) in the bone marrow in ER-α-positive primary breast cancer patients
RC Coombes, MT De Bella, G Tripuraneni, A Zaidi, S Anwer, DA Stephens, B Ward, HD Sinnett, MJ Slade
Circulating tumor cells and novel biomarkers for prognostic and biological of breast cancer
M Cristofanilli
Partial breast irradiation: why and how
FA Calvo, JA Díaz, Á Montero, A Álvarez González
Radiotherapy in early stage invasive breast cancer: current tendencies
JA Diaz-Gonzalez, KH Shin, R Martinez-Monge, M Zelefsky
Adjuvant chemotherapy for operable breast cancer: old vs new schema
P Valagussa, L Gianni, G Bonadonna
Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial
S Rodenhuis, M Bontenbal, LVAM Beex, WM Smit, MA Nooij, EE Voest, E van der Wall, P Hupperets, Harm van Tinteren, HL Peterse, MJ van de Vijver, EGE de Vries
SOLTI (Solid Tumor Intensification) Group experience with high-dose chemotherapy treatment for early breast carcinoma
H Cortés Funes, A Lluch, M Climent, JJ López, B Ojeda, J Hornedo, E Ciruelos, J Baselga
Letrozole efficacy is related to human aromatase CYP19 single nucleotide polymorphisms (SNPs) in metastatic breast cancer
R Colomer, M Monzo, I Tusquets, J Rifa, JM Baena, A Barnadas, L Calvo, F Carabantes, C Crespo, M Muñoz, A Llombart, A Plazaola, E Alba, D Fuster, M Gilabert, B Lloveras
Cyclo-oxygenase-2 expression is associated with poor clinical outcome after doxorubicin-based chemotherapy in node-positive breast cancer: integration of tissue microarray
SH Han, JS Kim, SS Jung, BJ Song
Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
IP Callejo, J Brito, R Alves, P Dias, M Limbert, N Abecasis, J Faria, J Weinholtz, S André, C Costa, O Almeida, M e Sousa
Fibroadenoma of breast in Iranian women between 1994 and 2004
A Abdollahi, S Shalbaf
Nanoparticulate paclitaxel loaded into sterically stabilized mixed phospholipid micelles to improve chemotherapy of breast cancer
I Rubinstein, A Krishnadas, LR Peddakota, H Önyüksel
Clinical profile and management of bilateral breast cancer
V Suryanarayana Deo, D Shridhar, NK Shukla, S Kumar, J Purkayastha, V Raina, GK Rath
Adjuvant radiotherapy after surgery in breast cancer: evaluation of acute toxicity
MA Molinaro, C Vaccaro
Breast cancer-screening programme amongst unpriviledged women in Charleroi (Hainaut), Belgium
F Bastin, M Lejeune
A performance study of different soft-computing procedures for automatic detection of breast cancer malignancy
M Ortega-Moral, V Gómez-Verdejo, J Arenas-García, LA Azpicueta-Ruiz, M Lázaro-Gredilla, J Madrid-Sánchez, E López-Beltrán, AR Figueiras-Vidal
A phase II randomized trial of doxorubicin (DXR) and gemcitabine (GMZ) administered in patients with metastatic breast cancer (MBC)
A Bensalem, K Bouzid
The axillary study with ultrasound and cytological puncture with fine needle in invasive breast cancer.
M Izquierdo, M Cusido, D Dexeus, J Feu, F Tresserra, C Ara, B Navarro, L Lopez Marin, R Fabregas
Expression of c-met gene in invasive ductal carcinomas
CH Park, MH Lee, ES Chang, BJ Song, SS Jung
[ASCRIT] Antisense chemoradioimmunotherapy consisting of anti-POEM (Arg-Gly-Asp) scFv linked onto high-energy radioisotopes, vinorelbine-tartrate and 21-nucleotide double-stranded siRNA targeted to DNMT1 induce apoptosis in metastatic breast cancer (MBC) characterized by hypermethylated p53, p16, RASSF1A, RAR-b2, BRCA2, H1C1, ESRI1, CDH1, Trbeta1, GSTP1, CCND2 and overexpression of bcl-2, cdc25c, Raf-1 and α8β1 integrin
J Giannios, P Lambrinos, E Maragudakis, N Alexandropoulos